Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Non-Squamous Non-Small Cell Lung Cancer”

225 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 225 results

Testing effectiveness (Phase 2)Study completedNCT00550537
What this trial is testing

Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 116
Testing effectiveness (Phase 2)Study completedNCT00278460
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 49
Testing effectiveness (Phase 2)Study completedNCT00227708
What this trial is testing

Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
UNICANCER 58
Not applicableTemporarily pausedNCT03987555
What this trial is testing

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Who this might be right for
Solid Tumor, AdultMetastatic Nonsmall Cell Lung CancerAnatomic Stage IV Breast Cancer AJCC v8+25 more
Wake Forest University Health Sciences 55
Early research (Phase 1)Study completedNCT01727076
What this trial is testing

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck CarcinomaRecurrent Non-Small Cell Lung Carcinoma+11 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Looking for participantsNCT06463665
What this trial is testing

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Who this might be right for
Advanced Non-squamous Non-small-cell Lung CancerAdvanced Squamous Non-Small Cell Lung CarcinomaMetastatic Non-squamous Non Small Cell Lung Cancer+5 more
Genelux Corporation 142
Not applicableTemporarily pausedNCT03253575
What this trial is testing

CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2

Who this might be right for
Adult Solid Tumor
Mitra RxDx, Inc. 800
Large-scale testing (Phase 3)Study completedNCT00003685
What this trial is testing

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

Who this might be right for
FatigueLung CancerNausea and Vomiting+3 more
NCIC Clinical Trials Group 230
Early research (Phase 1)Ended earlyNCT01249443
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Who this might be right for
HIV InfectionRecurrent Anal CancerRecurrent Breast Cancer+31 more
AIDS Malignancy Consortium 17
Early research (Phase 1)WithdrawnNCT01383668
What this trial is testing

Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage IIIA Non-small Cell Lung Cancer+3 more
Mayo Clinic
Large-scale testing (Phase 3)Study completedNCT03676192
What this trial is testing

To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of Lung
Celltrion 689
Early research (Phase 1)Active Not RecruitingNCT05537740
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 129
Testing effectiveness (Phase 2)UnknownNCT04846452
What this trial is testing

Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC

Who this might be right for
Metastatic NSCLCRecurrent NSCLCAdvanced Non-Small Cell Squamous Lung Cancer
The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)Study completedNCT00585377
What this trial is testing

Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer

Who this might be right for
Cancer
University of Utah 50
Testing effectiveness (Phase 2)Ended earlyNCT03709706
What this trial is testing

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

Who this might be right for
Neoplasms
GlaxoSmithKline 34
Early research (Phase 1)Study completedNCT01302808
What this trial is testing

Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
University of Texas Southwestern Medical Center 17
Large-scale testing (Phase 3)Study completedNCT00806923
What this trial is testing

Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 1,044
Large-scale testing (Phase 3)UnknownNCT01656551
What this trial is testing

MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIIB
National Cancer Institute, Naples 232
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT03110978
What this trial is testing

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Atypical Carcinoid TumorLung Neuroendocrine NeoplasmLung Non-Small Cell Squamous Carcinoma+11 more
M.D. Anderson Cancer Center 140
Next Page